Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial
Top Cited Papers
- 7 February 2019
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 393 (10175), 1021-1032
- https://doi.org/10.1016/s0140-6736(19)30195-3
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Neurological Disorders and Stroke (1U01NS080824)
- Genentech
- National Institutes of Health
This publication has 41 references indexed in Scilit:
- Minimally Invasive Surgery Plus Recombinant Tissue-type Plasminogen Activator for Intracerebral Hemorrhage Evacuation Decreases Perihematomal EdemaStroke, 2013
- Minimally Invasive Surgery for Spontaneous Supratentorial Intracerebral HemorrhageStroke, 2012
- Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: Design, Methods, and RationaleNeurocritical Care, 2011
- Guidelines for the Management of Spontaneous Intracerebral HemorrhageStroke, 2010
- The health loss from ischemic stroke and intracerebral hemorrhage: evidence from the North East Melbourne Stroke Incidence Study (NEMESIS)Health and Quality of Life Outcomes, 2010
- The ICH ScoreStroke, 2001
- Stereotactic Computed Tomographic–Guided Aspiration and Thrombolysis of Intracerebral HematomaStroke, 2000
- Ultra-early clot aspiration after lysis with tissue plasminogen activator in a porcine model of intracerebral hemorrhage: edema reduction and blood-brain barrier protectionJournal of Neurosurgery, 1999
- The ABCs of Measuring Intracerebral Hemorrhage VolumesStroke, 1996
- Explanatory and pragmatic attitudes in therapeutical trialsJournal of Chronic Diseases, 1967